Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone

Anna L. Godfrey, Edwin Chen, Francesca Pagano, Christina A. Ortmann, Yvonne Silber, Beatriz Bellosillo, Paola Guglielmelli, Claire N. Harrison, John T. Reilly, Frank Stegelmann, Fontanet Bijou, Eric Lippert, Mary F. McMullin, Jean-Michel Boiron, Konstanze Döhner, Alessandro M. Vannucchi, Carlos Besses, Peter J. Campbell, Anthony R. Green

Blood (2012) 120 (13): 2704–2707.

https://doi.org/10.1182/blood-2012-05-431791

Published: 2012

Includes: Supplemental data

Journal Articles

Rapid and Sustained Engraftment of a Single Allogeneic Ex-Vivo Expanded Cord Blood Unit (CBU) After Reduced Intensity Conditioning (RIC) in Adults. Preliminary Results of a Prospective Trial

Noel Milpied, MD, Bernard Dazey, MD, Zoran Ivanovic, MD PHD, Pascale Duchez, Stephane Vigouroux, MD, Reza Tabrizi, MD, Arnaud Pigneux, MD, PhD, Marie-Sarah Dilhuydy, MD, Krimo Bouabdallah, MD, Thibaut Leguay, MD, Mathieu Sauvezie, Xavier Lafarge, MD, Gerald Marit, MD, PhD, Jean-Michel Boiron, MD, PhD

Blood (2011) 118 (21): 486.

https://doi.org/10.1182/blood.V118.21.486.486

Published: 2011

Journal Articles

The Prophylactic Use of G-CSF During Induction and Consolidation of Adults with Acute Lymphoblastic Leukemia Is Associated with Reduced Risk of Relapse and Improved Leukemia-Free Survival. A Joint Analysis of Five Randomized Trials on Behalf of the European Working Group for Adult ALL (EWALL)

Sebastian Giebel, MD, Xavier Thomas, MD, PhD, Helene Hallbook, MD, Klaus Geissler, MD, Jean-Michel Boiron, MD, PhD, Françoise Huguet, MD, Bengt Smedmyr, MD, PhD, Elisabeth Koller, MD, Andrzej Hellmann, MD, Jerzy Holowiecki, MD

Blood (2010) 116 (21): 2130.

https://doi.org/10.1182/blood.V116.21.2130.2130

Published: 2010

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

Ex-Vivo Expanded Peripheral Blood Stem Cells (EVEC) Compared with Un Manipulated Peripheral Blood Stem Cells (PBSC) Autologous Transplantation for Multiple Myeloma: A Pair Match Analysis.

Noel-Jean Milpied, MD, Gerald Marit, Bernard Dazey, Jean-Michel Boiron, MD, PhD, Zoran Ivanovic, Carine Foucaud, Fontanet Bijou, Krimo Bouabdallah, MD, Anna Schmitt, Mathieu Sauvezie, Christian Cailliot, MD, Josy Reiffers

Blood (2009) 114 (22): 502.

https://doi.org/10.1182/blood.V114.22.502.502

Published: 2009

Journal Articles

Functional and Phenotypic Characterizations of Granulocyte-Colony Stimulating Factors Mobilzed CD34+ Cells.

Fontanet Bijou, Muhamed Hammoud, Marija Vlaski, Pascale Duchez, Noel-Jean Milpied, MD, Xavier Lafarge, Jean Chevaleyre, Bouzgarrou Ridha, Bernard Dazey, Jean-Michel Boiron, MD, PhD, Zoran Ivanovic

Blood (2009) 114 (22): 2143.

https://doi.org/10.1182/blood.V114.22.2143.2143

Published: 2009

Journal Articles

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Martin H. Dreyling, MD, Eva Hoster, PhD, Achiel Van Hoof, Bernd Metzner, Christian Gisselbrecht, Michael Pfreundschuh, MD, PhD, Marcel Reiser, Lorenz H. Truemper, MD, PhD, Hjalmar Steinhauer, Jean-Michel Boiron, MD, PhD, Marc Boogaerts, MD, PhD, Vittorio Silingardi, J.C. Kluin- Nelemans, MD, PhD, Michael Unterhalt, Wolfgang Hiddemann

Blood (2008) 112 (11): 769.

https://doi.org/10.1182/blood.V112.11.769.769

Published: 2008

Journal Articles

Impact of the Use of Thalidomide, Lenalidomide, or Bortezomib, Compared to“standard Chemotherapy”, as “salvage” Before Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-AT), for Relapsed Multiple Myeloma

Anna Schmitt, Reza Tabrizi, MD, Stephane Vigouroux, Mathieu Sauvezie, Carine Foucaud, Krimo Bouabdallah, marie-Sarah Dilhuydy, Arnaud Pigneux, MD, PhD, Thibaut Leguay, didier-Innocent Adiko, Jean-Michel Boiron, MD, PhD, Gerald Marit, Noel-Jean Milpied, PhD

Blood (2008) 112 (11): 4310.

https://doi.org/10.1182/blood.V112.11.4310.4310

Published: 2008

Journal Articles

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Reza Tabrizi, Stephane Vigouroux, Arnaud Pigneux, Thibaut Leguay, Krimo Bouabdallah, Marie-Sarah Dilhuydy, Carine Foucaud, Pierre-Yves Dumas, Axelle Lascaux, Mohamed Zarrouk, Jean-Michel Boiron, MD, PhD, Fontanet Bijou, Pascal Turlure, Cyril Melot, Gerald Marit, Noel Milpied

Blood (2008) 112 (11): 4331.

https://doi.org/10.1182/blood.V112.11.4331.4331

Published: 2008

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Louis Terriou, Zina Chir, Helene Esperou, Jean-Michel Boiron, Jean-Paul Vernant, Nicole Gratecos, Mauricette Michalet, Noel Milpied, Jean-Pierre Jouet, Ibrahim Yakoub-Agha, Societe Francaise de Greffe de Moelle Osseuse et de Therapie Cellulaire

Blood (2007) 110 (11): 4924.

https://doi.org/10.1182/blood.V110.11.4924.4924

Published: 2007

Journal Articles

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Mohamad Mohty, MD, PhD, Franck E. Nicolini, MD, PhD, Jean-Michel Boiron, MD, Hélène Espérou, MD, Michel Attal, MD, PhD, Noel Milpied, MD, Bernard Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yackoub-Agha, MD, PhD, Jean-Henri Bourhis, MD, PhD, Bernard Rio, MD, Eric Deconninck, MD, Marc Renaud, MD, Mohamad Sobh, PhD, Nicole Raus, Didier Blaise, MD

Blood (2007) 110 (11): 1085.

https://doi.org/10.1182/blood.V110.11.1085.1085

Published: 2007

Journal Articles

Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial.

Emmanuelle Tavernier, MD, Jean-Michel Boiron, MD, Francoise Huguet, MD, Kenneth Francis Bradstock, MD, Norbert Vey, MD, Tibor Kovacsovics, MD, Andre Delannoy, MD, Nathalie Fegueux, MD, Pierre Fenaux, MD, Aspasia Stamatoullas, MD, Olivier Tournilhac, MD, Agnes Buzyn, MD, Oumedaly Reman, MD, Christiane Charrin, MD, Claude Boucheix, MD, Jean Gabert, MD, Veronique Lheritier, CRA, Jean-Paul Vernant, MD, Xavier Thomas, MD

Blood (2006) 108 (11): 1876.

https://doi.org/10.1182/blood.V108.11.1876.1876

Published: 2006

Journal Articles

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Andrea Toma, Marie-Lorraine Balere-Appert, Zina Chir, Jean-Michel Boiron, Pierre Bordigoni, Gerard Socie, Jean-Paul Vernant, Marc Renaud, Noel-Jean Milpied, Mauricette Michallet, Eric Deconninck, Denis Guyotat, Frederic Garban, Anne Sirvent, Nathalie Contentin, Didier Blaise, Colette Raffoux, Agnes Buzyn

Blood (2006) 108 (11): 3149.

https://doi.org/10.1182/blood.V108.11.3149.3149

Published: 2006

Journal Articles

Unrelated Allogeneic Stem Cell Transplantation for Severe Acquired Aplastic Anemia: Has Outcome Improved?.

Sebastien Maury, M.-Lorraine Balere-Appert, Zina Chir, J.-Michel Boiron, Claire Galambrun, Karima Yakouben, Pierre Bordigoni, Aude Marie-Cardine, Noel Milpied, Justina Kanold, Natacha Maillard, J.-Henri Bourhis, Alain Fischer, Patrick Lutz, Mauricette Michallet, Didier Blaise, Catherine Cordonnier, Colette Raffoux, Gerard Socie

Blood (2006) 108 (11): 3105.

https://doi.org/10.1182/blood.V108.11.3105.3105

Published: 2006

Journal Articles

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Noel-Jean Milpied, MD, Reza Tabrizi, MD, Thierry Guillaume, MD, Patrice Chevallier, MD, Arnaud Pigneux, MD, Jean Michel Boiron, MD, Philippe Moreau, MD, Beatrice Mahe, MD, Thibaut Leguay, MD, Krimo Bouabdallah, MD, Nadine Morineau, MD, Jacques Delaunay, MD, Cyril Melot, Beatrice Saulquin, Gerald Marit, MD, Jean Luc Harousseau, MD

Blood (2006) 108 (11): 3015.

https://doi.org/10.1182/blood.V108.11.3015.3015

Published: 2006

Journal Articles

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Jean Michel Boiron, MD, Hélène Esperou, MD, Noel Milpied, MD, Nathalie Dhédin, MD, Didier Blaise, MD

Blood (2005) 106 (11): 45.

https://doi.org/10.1182/blood.V106.11.45.45

Published: 2005

Journal Articles

Low Progression-Free Survival for High-Risk Patients Treated with Reduced-Intensity Conditioning Regimen Allogeneic Stem Cell Transplantations with Volunteer Unrelated Donors.

Reza Tabrizi, MD, Fontanet Bijou, MD, Krimo Bouabdallah, MD, Thibaut Leguay, MD, Gerald Marit, MD, Arnaud Pigneux, MD, Aurelie Gomez, MD, Francis Belloc, Xavier Lafarge, Jean-Michel Boiron, MD, PhD

Blood (2005) 106 (11): 5432.

https://doi.org/10.1182/blood.V106.11.5432.5432

Published: 2005

Journal Articles

Secondary or Concomitant Neoplasms among Adults Diagnosed with Acute Lymphoblastic Leukemia (ALL) and Treated According to the LALA-87 and LALA-94 Trials.

Blood (2005) 106 (11): 1826.

https://doi.org/10.1182/blood.V106.11.1826.1826

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Didier Blaise, Zina Chir, Michel Attal, Jean-Henri Bourhis, Jean-Jacques Sotto, Jean-Michel Boiron, Noel Milpied, Jean-Yves Cahn, Bernard Rio, Bruno Lioure, Francois Guilhot, C. Berthou, Agnes Buzyn, Mauricette Michallet

Blood (2005) 106 (11): 1140.

https://doi.org/10.1182/blood.V106.11.1140.1140

Published: 2005

Journal Articles

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Thomas Prebet, MD, Quoc-Hung Le, MD, Jean-Michel Boiron, MD, Didier Blaise, MD, Anne Huynh, MD, Ibrahim Yakoub-Agha, MD, Hélène Esperou, MD, Fréderic Garban, MD, PhD, Jean Henri Bourhis, MD, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 1146.

https://doi.org/10.1182/blood.V106.11.1146.1146

Published: 2005

NARROW

JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone

Rapid and Sustained Engraftment of a Single Allogeneic Ex-Vivo Expanded Cord Blood Unit (CBU) After Reduced Intensity Conditioning (RIC) in Adults. Preliminary Results of a Prospective Trial

The Prophylactic Use of G-CSF During Induction and Consolidation of Adults with Acute Lymphoblastic Leukemia Is Associated with Reduced Risk of Relapse and Improved Leukemia-Free Survival. A Joint Analysis of Five Randomized Trials on Behalf of the European Working Group for Adult ALL (EWALL)

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Ex-Vivo Expanded Peripheral Blood Stem Cells (EVEC) Compared with Un Manipulated Peripheral Blood Stem Cells (PBSC) Autologous Transplantation for Multiple Myeloma: A Pair Match Analysis.

Functional and Phenotypic Characterizations of Granulocyte-Colony Stimulating Factors Mobilzed CD34+ Cells.

Early Consolidation with Myeloablative Radiochemotherapy Followed by Autologous Stem Cell Transplantation in First Remission in Mantle Cell Lymphoma: Long Term Follow up of a Randomized Trial of the

Impact of the Use of Thalidomide, Lenalidomide, or Bortezomib, Compared to“standard Chemotherapy”, as “salvage” Before Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC-AT), for Relapsed Multiple Myeloma

Ciclosporine and Metotrexate Reduce the Risk of High Grade Acute Gvhd after Busulfan, Fludarabine and Anti-Thymocyte Globulin conditioning Regimen in Comparison with Cyclosporine Alone

Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.

Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial.

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Unrelated Allogeneic Stem Cell Transplantation for Severe Acquired Aplastic Anemia: Has Outcome Improved?.

Allogeneic Stem Cell Transplantation with Reduced Intensity Conditionning Regimen (RIC) for Adult Patients with AML: Same Results in Secondary and De Novo AML.

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Low Progression-Free Survival for High-Risk Patients Treated with Reduced-Intensity Conditioning Regimen Allogeneic Stem Cell Transplantations with Volunteer Unrelated Donors.

Secondary or Concomitant Neoplasms among Adults Diagnosed with Acute Lymphoblastic Leukemia (ALL) and Treated According to the LALA-87 and LALA-94 Trials.

Allogeneic Stem Cell Transplantation (allo-SCT) from a HLA Identical Sibling for CR1 AML Patients Aged above 55 Years Old after a Reduced Intensity Conditioning: A Survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only